DE60037113D1 - Glycosyltransferase inhibitoren - Google Patents
Glycosyltransferase inhibitorenInfo
- Publication number
- DE60037113D1 DE60037113D1 DE60037113T DE60037113T DE60037113D1 DE 60037113 D1 DE60037113 D1 DE 60037113D1 DE 60037113 T DE60037113 T DE 60037113T DE 60037113 T DE60037113 T DE 60037113T DE 60037113 D1 DE60037113 D1 DE 60037113D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibitors
- glycosyltransferase
- glycosyltransferase inhibitors
- glyscosyltranferase
- glycosyltransferases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13615099P | 1999-05-24 | 1999-05-24 | |
US57712099A | 1999-05-24 | 1999-05-24 | |
US136150P | 1999-05-24 | ||
US577120 | 1999-05-24 | ||
PCT/US2000/014360 WO2001068095A1 (en) | 1999-05-24 | 2000-05-24 | Glycosyltransferase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60037113D1 true DE60037113D1 (de) | 2007-12-27 |
DE60037113T2 DE60037113T2 (de) | 2008-09-18 |
Family
ID=26834046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60037113T Expired - Lifetime DE60037113T2 (de) | 1999-05-24 | 2000-05-24 | Glycosyltransferase inhibitoren |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1185269B1 (de) |
AT (1) | ATE378421T1 (de) |
DE (1) | DE60037113T2 (de) |
WO (1) | WO2001068095A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0421368D0 (en) * | 2004-09-25 | 2004-10-27 | Univ York | Glycosyltransferase assay |
EP2720044A1 (de) * | 2012-10-15 | 2014-04-16 | National University of Ireland, Galway | Sialyltransferase ST3GAL6 als Marker für multiples Myelom |
CN105579578A (zh) | 2013-08-12 | 2016-05-11 | 贝纳罗亚研究院·弗吉尼亚梅森 | 用于免疫调节的4-甲基伞形酮治疗 |
CN111437283A (zh) * | 2020-03-09 | 2020-07-24 | 吉林大学 | β1,4-半乳糖基转移酶抑制剂在制备治疗癌症的药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992016640A1 (en) * | 1991-03-18 | 1992-10-01 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
CZ120398A3 (cs) * | 1995-09-08 | 1998-12-16 | Novo Nordisk A/S | Použití 2-alkylpyrrolidinových derivátů pro přípravu léčiva pro léčbu diabetu, 2-alkylpyrrolidiné deriváty |
US5770407A (en) * | 1996-12-10 | 1998-06-23 | The Scripps Research Institute | Process for preparing nucleotide inhibitors of glycosyltransferases |
-
2000
- 2000-05-24 EP EP00936281A patent/EP1185269B1/de not_active Expired - Lifetime
- 2000-05-24 WO PCT/US2000/014360 patent/WO2001068095A1/en active IP Right Grant
- 2000-05-24 AT AT00936281T patent/ATE378421T1/de not_active IP Right Cessation
- 2000-05-24 DE DE60037113T patent/DE60037113T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60037113T2 (de) | 2008-09-18 |
EP1185269A4 (de) | 2004-12-01 |
EP1185269B1 (de) | 2007-11-14 |
EP1185269A1 (de) | 2002-03-13 |
ATE378421T1 (de) | 2007-11-15 |
WO2001068095A1 (en) | 2001-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001038532A3 (en) | Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors | |
GB2386224A (en) | Global electronic trading system | |
NO20005224D0 (no) | BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse | |
WO2005023824A3 (en) | Methods for inhibiting tumor cell proliferation | |
WO2005028443A3 (en) | Protein tyrosine kinase enzyme inhibitors | |
TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
RS20060320A (en) | Substituted indazole-o-glucosides | |
DK1409459T3 (da) | ECL mærker, som har forbedrede, non-specifikke bindingsegenskaber, fremgangsmåder til anvendelse deraf, og kits indeholdende samme. | |
DK1311269T3 (da) | Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem | |
MY142777A (en) | Substituted indole-o-glucosides | |
MX9705273A (es) | Inhibidores de prenil transferasas. | |
NO20013451L (no) | 1-Heterocyklus-substituerte diarylaminer | |
UA86042C2 (en) | Substituted indazole-o-glucosides | |
AU3940702A (en) | Dna methyl transferase inhibitors | |
AU2001268449A1 (en) | Toxicity typing using liver stem cells | |
WO2003048301A3 (en) | Anti-hla-dr antibodies and the methods of using thereof | |
MX2007010332A (es) | Metodos y composiciones para promover adhesion o migracion de celula endotelial. | |
GB2377295A (en) | Conversational dealing system | |
TW200632950A (en) | Method to form a thin film resistor | |
AU2003290592A1 (en) | Antitumor benzoylsulfonamides | |
TW200630348A (en) | Tadalafil crystal forms and processes for preparing them | |
IL138688A0 (en) | Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme | |
DE60332600D1 (de) | Selektive elution von immobilisierten multiplexierten primerverlängerungsprodukten | |
IL139852A0 (en) | Monoclonal antibodies directed against the g3bp protein, and uses | |
DE60037113D1 (de) | Glycosyltransferase inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |